CAS: 848942-61-0 - Sapitinib
Formula:C23H25ClFN5O3
InChI:InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)
InChI key:InChIKey=DFJSJLGUIXFDJP-UHFFFAOYSA-N
SMILES:O=C(NC)CN1CCC(OC2=CC=3C(=NC=NC3NC=4C=CC=C(Cl)C4F)C=C2OC)CC1
- Synonyms:
- 1-Piperidineacetamide, 4-[[4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-
- 2-[4-[4-(3-Chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide
- 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy]quinazoline
- 4-[[4-[(3-Chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-methyl-1-piperidineacetamide
- Azd-8931
- Azd8931
- Sapatinib
- Sapitinib
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
AZD8931 REF: IN-DA00G3RJCAS: 848942-61-0 | 98% | 156.00 €~658.00 € | Thu 02 Jan 25 | |
Sapitinib REF: TM-T6092CAS: 848942-61-0 | 98.35% - 99.83% | 38.00 €~235.00 € | Thu 09 Jan 25 | |
Sapatinib REF: TR-S159275CAS: 848942-61-0 | - - - | 2,167.00 € | Wed 12 Feb 25 | |
2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-N-methylacetamidef REF: 3D-FC43349CAS: 848942-61-0 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00G3RJ
5mg | 156.00 € | ||
25mg | 173.00 € | ||
50mg | 291.00 € | ||
100mg | 658.00 € |
Sapitinib
Ref: TM-T6092
2mg | 38.00 € | ||
5mg | 56.00 € | ||
10mg | 85.00 € | ||
25mg | 109.00 € | ||
50mg | 163.00 € | ||
100mg | 235.00 € | ||
1mL*10mM (DMSO) | 59.00 € |
Sapatinib
Controlled ProductRef: TR-S159275
250mg | 2,167.00 € |
2-(4-(4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-N-methylacetamidef
Ref: 3D-FC43349
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |